Rankings
▼
Calendar
CRBU Q1 2020 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CRBU
Caribou Biosciences, Inc.
$181M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$10M
-613.1% margin
Net Income
-$10M
-576.1% margin
EPS (Diluted)
$-0.35
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$10M
Stock-Based Comp.
$237,000
← FY 2020
All Quarters
Q2 2020 →